-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GjM4IoVfPRwIm8FHMy2CSPahpwlJbEHATHnHnaCtKD8LPvyYYHFkhoJf+CUoTWIQ cfhZ3+5r3/YCGtoypsG1lw== 0000051396-95-000028.txt : 19951106 0000051396-95-000028.hdr.sgml : 19951106 ACCESSION NUMBER: 0000051396-95-000028 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 19950930 FILED AS OF DATE: 19951103 SROS: CSX SROS: NYSE SROS: PSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MALLINCKRODT GROUP INC CENTRAL INDEX KEY: 0000051396 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 361263901 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00483 FILM NUMBER: 95587234 BUSINESS ADDRESS: STREET 1: 7733 FORSYTH BLVD CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3148545299 MAIL ADDRESS: STREET 1: 7733 FORSYTH BLVD CITY: ST LOUIS STATE: MO ZIP: 63105 FORMER COMPANY: FORMER CONFORMED NAME: IMCERA GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL MINERALS & CHEMICAL CORP DATE OF NAME CHANGE: 19900614 10-Q 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF --- THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 1995 OR --- TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-483 ______________________________ MALLINCKRODT GROUP INC. (Exact name of registrant as specified in its charter) New York 36-1263901 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7733 Forsyth Boulevard St. Louis, Missouri 63105-1820 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 314-854-5200 ______________________________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X. No . Applicable Only To Issuers Involved In Bankruptcy Proceedings During The Preceding Five Years: Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes . No . Applicable Only To Corporate Issuers: Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. 76,529,742 shares excluding 10,586,547 treasury shares as of September 30, 1995. PART I. FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS (UNAUDITED). The accompanying interim condensed consolidated financial statements of Mallinckrodt Group Inc. (the Company or Mallinckrodt) do not include all disclosures normally provided in annual financial statements. These financial statements, which should be read in conjunction with the consolidated financial statements contained in Mallinckrodt's 1995 Annual Report to Shareholders, are unaudited but include all adjustments which Mallinckrodt's management considers necessary for a fair presentation. These adjustments consist of normal recurring accruals except as discussed in Note 1 of the Notes to Condensed Consolidated Financial Statements. Interim results are not necessarily indicative of the results for the fiscal year. All references to years are to fiscal years ended June 30 unless otherwise stated. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions except per share amounts) Three Months Ended September 30, ------------------- 1995 1994 ------- ------- Net sales $492.1 $448.6 Operating costs and expenses: Cost of goods sold 268.3 248.3 Selling, administrative and general expenses 138.9 123.7 Research and development expenses 24.1 23.2 Other operating income, net (3.2) (2.1) ------- ------- Total operating costs and expenses 428.1 393.1 ------- ------- Operating earnings 64.0 55.5 Equity in pre-tax earnings of joint venture 7.3 6.1 Interest and other nonoperating expense, net (.4) (.3) Interest expense (13.8) (12.0) ------- ------- Earnings from continuing operations before income taxes 57.1 49.3 Income tax provision 21.4 18.8 ------- ------- Earnings from continuing operations 35.7 30.5 Discontinued operations, net of income taxes of $2.1 million in each year 3.5 3.4 ------- ------- Net earnings 39.2 33.9 Preferred stock dividends (.1) (.1) ------- ------- Available for common shareholders $ 39.1 $ 33.8 ======= ======= Earnings per common share Continuing operations $.46 $.40 Discontinued operations .04 .04 ----- ----- Net earnings $.50 $.44 ===== ===== (See Notes to Condensed Consolidated Financial Statements on page 5.) CONDENSED CONSOLIDATED BALANCE SHEET (In millions except share and per share amounts) September 30, June 30, 1995 1995 ------------- ---------- ASSETS Current assets: Cash and cash equivalents $ 88.2 $ 60.6 Trade receivables, less allowances of $15.2 at September 30 and $13.5 at June 30 368.2 398.3 Inventories 446.0 412.9 Net current assets of discontinued operations 22.9 9.8 Deferred income taxes 53.6 53.1 Other current assets 59.3 56.7 --------- --------- Total current assets 1,038.2 991.4 Investments and long-term receivables, less allowances of $15.4 at September 30 and $17.0 at June 30 179.0 165.5 Property, plant and equipment, net 987.7 978.2 Intangible assets 532.8 527.6 Net noncurrent assets of discontinued operations 25.8 24.6 Deferred income taxes .8 .7 --------- --------- Total assets $2,764.3 $2,688.0 ========= ========= LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term debt $ 273.8 $ 197.5 Accounts payable 146.2 181.8 Accrued liabilities 319.8 332.7 Income taxes payable 43.8 4.8 Deferred income taxes 1.9 2.7 --------- --------- Total current liabilities 785.5 719.5 Long-term debt, less current maturities 498.5 501.5 Deferred income taxes 72.9 76.8 Postretirement benefits 144.9 142.7 Other noncurrent liabilities and deferred credits 79.0 76.0 --------- --------- Total liabilities 1,580.8 1,516.5 Shareholders' equity: 4 Percent cumulative preferred stock 11.0 11.0 Common stock, par value $1, authorized 300,000,000 shares; issued 87,116,289 shares as of September 30 and June 30 87.1 87.1 Capital in excess of par value 276.9 274.1 Reinvested earnings 1,012.8 984.5 Foreign currency translation (13.7) (9.3) Treasury stock, at cost (190.6) (175.9) --------- --------- Total shareholders' equity 1,183.5 1,171.5 --------- --------- Total liabilities and shareholders' equity $2,764.3 $2,688.0 ========= ========= (See Notes to Condensed Consolidated Financial Statements on page 5.) CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (In millions) Three Months Ended September 30, ------------------ 1995 1994 ------ ------ CASH FLOW - OPERATING ACTIVITIES Net earnings $ 39.2 $ 33.9 Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation and amortization 34.4 35.5 Postretirement benefits 2.2 2.8 Undistributed equity in earnings of joint venture (5.6) (4.4) Deferred income taxes (4.6) (.3) Gains on disposals of assets (.4) (1.1) Other, net (9.1) (10.6) ------- ------- 56.1 55.8 Changes in noncash operating working capital: Accounts receivable 23.9 (3.8) Inventories (38.3) .7 Accounts payable, accrued liabilities and income taxes, net (5.2) (15.0) Discontinued operations, net (13.1) .6 Other, net (.8) (3.0) ------- ------- Net cash provided by operating activities 22.6 35.3 CASH FLOWS - INVESTING ACTIVITIES Capital expenditures (36.8) (48.2) Acquisition spending (2.1) (3.4) Proceeds from asset disposals .6 5.6 Other, net (7.9) 4.1 ------- ------- Net cash used by investing activities (46.2) (41.9) CASH FLOWS - FINANCING ACTIVITIES Increase (decrease) in short-term debt 76.7 6.8 Proceeds from long-term debt 98.8 .5 Payments on long-term debt (101.5) (2.8) Issuance of Mallinckrodt common stock 8.1 .9 Acquisition of treasury stock (20.0) Dividends paid (10.9) (9.7) ------- ------- Net cash used by financing activities 51.2 (4.3) ------- ------- Increase (decrease) in cash and cash equivalents 27.6 (10.9) Cash and cash equivalents at beginning of period 60.6 86.2 ------- ------- Cash and cash equivalents at end of period $ 88.2 $ 75.3 ======= ======= (See Notes to Condensed Consolidated Financial Statements on page 5.) CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (In millions except per share amounts) 1995 1994 -------- -------- 4 Percent cumulative preferred stock Balance at June 30 and September 30 $ 11.0 $ 11.0 Common stock Balance at June 30 and September 30 87.1 87.1 Capital in excess of par value Balance at June 30 274.1 268.2 Stock options exercised 2.8 .3 --------- --------- Balance at September 30 276.9 268.5 Reinvested earnings Balance at June 30 984.5 846.4 Net earnings 39.2 33.9 Dividends 4 Percent cumulative preferred stock ($1.00 per share) (.1) (.1) Common stock ($.14 per share in 1995 and $.125 per share in 1994) (10.8) (9.6) --------- --------- Balance at September 30 1,012.8 870.6 Foreign currency translation Balance at June 30 (9.3) (34.2) Translation adjustment (4.4) 15.3 --------- --------- Balance at September 30 (13.7) (18.9) Treasury stock Balance at June 30 (175.9) (162.6) Purchase of common stock (20.0) Stock options exercised 5.3 .6 Restricted stock awards (4.1) --------- --------- Balance at September 30 (190.6) (166.1) --------- --------- Total shareholders' equity $1,183.5 $1,052.2 ========= ========= (See Notes to Condensed Consolidated Financial Statements on page 5.) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. Effective October 16, 1995, the Company's Veterinary subsidiary completed the sale of its animal feed ingredients business unit. Gross proceeds from the sale were $110 million. Results for the feed ingredients business have been accounted for as a discontinued operation and, accordingly, prior year results have been restated. Feed ingredients net sales were $37.2 million and $39.1 million and operating earnings were $7.0 million and $6.7 million for the quarters ended September 30, 1995 and 1994, respectively. Net assets for the feed ingredients business have been segregated into their current and noncurrent components in the balance sheets presented. The Company anticipates realizing a gain on this transaction, net of costs associated with disposal, but cannot yet quantify the amount. 2. Provisions for income taxes were based on estimated annual effective tax rates for each fiscal year. 3. Earnings per common share were based on the weighted average number of common and common equivalent shares outstanding (77,924,740 and 77,556,978 for the three months ended September 30, 1995 and 1994, respectively). 4. The components of inventory include the following as of September 30, 1995: (In millions) Raw materials and supplies $ 133.6 Work in process 106.5 Finished goods 205.9 ------- $ 446.0 ======= 5. As of September 30, 1995, the Company has authorized and issued 100,000 shares, par value $100, 4 Percent cumulative preferred stock of which 98,330 shares are outstanding. Mallinckrodt also has authorized 1,400,000 shares, par value $1, of Series preferred stock, none of which is outstanding. Shares included in treasury stock were: September 30, June 30, 1995 1995 ------------- ---------- Common stock 10,586,547 10,365,203 4 Percent cumulative preferred stock 1,670 1,670 6. At September 30, 1995, common shares reserved were: Exercise of common stock purchase rights 87,187,574 Exercise of stock options and granting of stock awards 10,657,832 ---------- Total 97,845,406 ========== 7. Supplemental cash flow information for the three months ended September 30 included: (In millions) 1995 1994 ------ ------ Interest paid $10.6 $11.5 Income taxes paid $ 4.9 $11.4 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. RESULTS OF OPERATIONS General - ------- Earnings from continuing operations for the first quarter ended September 30, 1995 were $36 million, or 46 cents per share. This represents a 15 percent increase in per-share earnings from continuing operations compared with $31 million, or 40 cents per share, during the same period a year ago. Net sales for the quarter were up 10 percent to $492 million, compared to $449 million a year earlier. Net earnings for the first quarter were $39 million, or 50 cents per share, compared with $34 million, or 44 cents per share, during the same period a year ago. Both fiscal 1996 and fiscal 1995 first quarter results reflect reporting of the animal feed ingredients business as a discontinued operation, fiscal 1995 having been restated. A comparison of sales and operating earnings follows: (In millions) Three Months Ended September 30, ------------------ 1995 1994 ------ ------ Sales - ----- Mallinckrodt Chemical $ 153 $ 111 Mallinckrodt Medical 238 230 Mallinckrodt Veterinary 101 108 ------ ------ $ 492 $ 449 ====== ====== Operating earnings - ------------------ Mallinckrodt Chemical $ 8 $ 7 Mallinckrodt Medical 58 51 Mallinckrodt Veterinary 5 4 Corporate (7) (6) ------ ------ $ 64 $ 56 ====== ====== Business Segments - ----------------- MALLINCKRODT CHEMICAL Net Sales Three Months Ended (In millions) September 30, ------------------ 1995 1994 ------ ------ Catalyst, Performance & Lab Chemicals $ 96 $ 55 Pharmaceutical Specialties 57 56 ------ ------ $ 153 $ 111 ====== ====== Mallinckrodt Chemical, including its $7.3 million equity-investment share of earnings from the flavors joint venture, Tastemaker, achieved earnings of $15.5 million for the first quarter, up 22 percent over the prior year's $12.7 million. Net sales increased 38 percent compared to the corresponding prior year quarter. Catalyst, performance and lab chemicals sales increased 75 percent for the quarter. Results benefited from the acquisition of J.T. Baker Inc. and the reclassification of a small specialty chemical business to continuing operations, both occurring in 1995. Pharmaceutical specialties sales improved by 2 percent for the quarter. Continued strength in worldwide sales volume for medicinal narcotics was the main contributor to the increase. MALLINCKRODT MEDICAL Net Sales Three Months Ended (In millions) September 30, ------------------ 1995 1994 ------ ------ Imaging $ 161 $ 160 Anesthesiology & Critical Care 77 70 ------ ------ $ 238 $ 230 ====== ====== Mallinckrodt Medical's operating earnings for the quarter increased to $57.8 million, up 14 percent compared to the first quarter, of last year. Net sales for the first quarter improved 4 percent over the prior year first quarter. Imaging sales for the quarter were 1 percent higher than the corresponding prior year quarter. Improved nuclear medicine sales volumes were partially offset by lower growth in X-ray contrast media sales, principally from timing of orders and distributor inventory adjustments. Anesthesiology and critical care sales were up 10 percent largely from improved sales volumes of respiratory therapy products. MALLINCKRODT VETERINARY Net Sales Three Months Ended (In millions) September 30, ------------------ 1995 1994 ------ ------ Animal Health $ 101 $ 108 ====== ====== Mallinckrodt Veterinary's first quarter operating earnings were $5.0 million, up 19 percent compared to the same period last year, excluding feed ingredients for both current and prior year. Net sales on the same basis decreased 7 percent compared to the corresponding prior year quarter. Lower first quarter sales resulted from the exit of certain Latin American distributorships last fiscal year and lower animal productivity sales attributable to weather conditions in North America. Lower operating expenses contributed to the improvement in operating earniangs. Corporate Matters - ----------------- Corporate expense increased $.7 million for the first quarter compared to last year. The Company's effective tax rate for the first three months was 37.5 percent, compared to last year's 38.0 percent. This decrease reflects an earnings mix toward lower statutory tax rate jurisdictions and the utilization of certain operating losses. FINANCIAL CONDITION The Company's financial resources are expected to continue to be adequate to support existing businesses and fund new opportunities. Since June 30, 1995, cash and cash equivalents increased $28 million. Operations provided $113 million of cash, while acquisition and capital spending totaled $39 million. The Company's current ratio at September 30, 1995, was 1.3:1. Debt as a percentage of invested capital was 39 percent. The Company's Board of Directors previously authorized repurchase of a total of 42 million shares of its common stock. Thirty million shares have been repurchased under this authorization, .5 million during the quarter ended September 30, 1995. On April 8, 1992, a shelf registration statement was filed with the Securities and Exchange Commission (SEC) for $250 million of debt securities. As of September 30, 1995, $50 million of securities under the shelf remain unissued. On February 15, 1995, a shelf registration statement was filed with the SEC for $250 million of debt securities. On September 15, 1995, the Company issued $100 million of 6.75% notes due September 15, 2005, from this shelf registration. As of September 30, 1995, $150 million of securities under the shelf remain unissued. The Company has a $450 million private-placement commercial paper program. This program is backed by $650 million of U.S. lines of credit, $100 million available until March 1996 and $550 million available until November 1999. At September 30, 1995, commercial paper borrowings and borrowings under the U.S. credit lines amounted to $216 million and $90 million, respectively. At September 30, 1995, non-U.S. lines of credit totaling $280 million were also available and borrowings under these lines amounted to $38 million. The non- U.S. lines are cancelable at any time. Estimated capital spending for the year ending June 30, 1996, is approximately $200 million. PART II. OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS. Pierce County, WA -- In 1995, Centrum Properties Corporation filed an action against the Company and Olin Corporation concerning property that was owned by Olin between 1935 and 1963 and by the Company between 1963 and 1976. The suit alleges that the property's groundwater is contaminated with carbon tetrachloride, and that this contamination was caused by releases from the explosives manufacturing facility operated on the property first by Olin and then by the Company. Centrum is currently conducting a remedial investigation and feasibility study of the contamination pursuant to an Agreed Order with the Washington Department of Ecology. In the suit, Centrum seeks to recover its past clean-up costs as well as all future costs associated with remediating the carbon tetrachloride. Centrum, Olin and Mallinckrodt are currently discussing possible ways of resolving the dispute and allocating the clean-up costs. Given the uncertainties associated with these discussions, as well as the fact that the remedial investigation and feasibility study has not yet been completed, it is not possible to estimate at this time the Company's potential liability. There have not been any material developments in the legal proceedings previously reported in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 1995. ITEM 2. CHANGES IN SECURITIES. Not applicable. ITEM 3. DEFAULTS UPON SENIOR SECURITIES. Not applicable. ITEM 4. SUBMISSIION OF MATTERS TO A VOTE OF SECURITY HOLDERS. (a) The Annual Meeting of Shareholders was held October 18, 1995 in St. Louis, Missouri. (b) The following directors were elected at the Annual Meeting of Shareholders: Term expiring in 1998..................William L. Davis, III Term expiring in 1998..................Roberta S. Karmel Term expiring in 1998..................Brian M. Rushton, Ph.D. Term expiring in 1998..................Daniel R. Toll Term expiring in 1997..................Anthony Viscusi The following directors continue in office: Raymond F. Bentele Dr. Ronald G. Evens Alec Flamm C. Ray Holman Claudine B. Malone Morton Moskin Herve M. Pinet (c) Other matters voted upon at the Annual Meeting of Shareholders were: 1. Approval of Appointment of Independent Auditors. The appointment of Ernst & Young LLP, as independent auditors of the Registrant for the fiscal year ending June 30, 1996, was ratified by the affirmative vote of an aggregate of 65,932,668 shares of common and 4 percent cumulative preferred stock. A total of 92,330 shares of common and 4 percent cumulative preferred stock was voted against the appointment. Holders of 77,545 shares of common and 4 percent cumulative preferred stock abstained from voting. ITEM 5. OTHER INFORMTION Not applicable. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K. (a) Exhibits 11.1 Primary earnings per share computation for the three months ended September 30, 1995 and 1994. 11.2 Fully diluted earnings per share computation for the three months ended September 30, 1995 and 1994. 27 Financial Data Schedule. (b) Reports on Form 8-K. During the quarter and through the date of this report, the following reports on Form 8-K were filed. - Report dated September 8, 1995, under Item 5 regarding the MD&A and Financial Statements for the year ended June 30, 1995. - Report dated September 14, 1995, under Item 5 regarding plans to repurchase up to $250 million of company stock over the next five years. - Report dated October 17, 1995, under Item 5 regarding the completion of the sale of the feed ingredients business, increased quarterly dividend and plans for increased share repurchases. * * * * * * * * * * * * * * SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Mallinckrodt Group Inc. - ------------------------------ Registrant By: MICHAEL A. ROCCA By: WILLIAM B. STONE --------------------------- ------------------------ Michael A. Rocca William B. Stone Senior Vice President Vice President and and Chief Financial Officer Controller Date: November 3, 1995 EX-11.1 2 Exhibit 11.1 EARNINGS PER SHARE PRIMARY COMPUTATION ($ in millions except share and per share amounts)
Three Months Ended September 30, 1995 1994 - -------------------------------------------------------------------- Basis for computation of earnings per common and common equivalent shares: Earnings from continuing operations $ 35.7 $ 30.5 Deduct dividends on 4 Percent cumulative preferred stock (.1) (.1) -------- -------- Earnings from continuing operations available to common shareholders 35.6 30.4 Discontinued operations 3.5 3.4 -------- -------- Available for common shareholders $ 39.1 $ 33.8 ======== ======== Number of shares: Weighted average shares outstanding 76,712,609 76,898,893 Shares issuable upon exercise of stock options, net of shares assumed to be repurchased 1,212,131 658,085 ---------- ---------- 77,924,740 77,556,978 ========== ========== Earnings per common share: Continuing operations $.46 $.40 Discontinued operations .04 .04 ----- ----- Net earnings $.50 $.44 ====== ======
EX-11.2 3 Exhibit 11.2 EARNINGS PER SHARE FULLY DILUTED COMPUTATION ($ in millions except share and per share amounts)
Three Months Ended September 30, 1995 1994 - -------------------------------------------------------------------- Basis for computation of earnings per common and common equivalent shares: Earnings from continuing operations $ 35.7 $ 30.5 Deduct dividends on 4 Percent cumulative preferred stock (.1) (.1) -------- -------- Earnings from continuing operations available to common shareholders 35.6 30.4 Discontinued operations 3.5 3.4 -------- -------- Available for common shareholders $ 39.1 $ 33.8 ======== ======== Number of shares: Weighted average shares outstanding 76,712,609 76,898,893 Shares issuable upon exercise of stock options, net of shares assumed to be repurchased 1,386,320 720,674 ---------- ---------- 77,098,929 77,619,567 ========== ========== Earnings per common share: Continuing operations $.46 $.40 Discontinued operations .04 .04 ----- ----- Net earnings $.50 $.44 ====== ======
EX-27 4
5 This schedule contains summary financial information extracted from the balance sheet and income statement, and is qualified in its entirety by reference to such financial schedules. 1,000,000 3-MOS JUN-30-1996 SEP-30-1995 88 0 368 15 446 1038 1497 509 2,764 786 499 87 0 11 1,085 2,764 492 492 268 428 0 0 14 57 21 36 4 0 0 39 .50 .50
-----END PRIVACY-ENHANCED MESSAGE-----